Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.58 USD | -9.48% |
|
+0.18% | -36.28% |
08:11pm | Sector Update: Health Care Stocks Edge Higher in Afternoon Trading | MT |
06:06pm | Mizuho Securities Cuts Price Target on Apellis Pharmaceuticals to $49 From $52, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.28% | 5.04B | |
+2.99% | 94.76B | |
-4.34% | 37.58B | |
-11.21% | 33.3B | |
+75.79% | 27.92B | |
-13.72% | 15.85B | |
-3.65% | 13.79B | |
-12.31% | 11.51B | |
+184.77% | 10.9B | |
-54.13% | 9.27B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Apellis Pharmaceuticals Insider Sold Shares Worth $1,451,835, According to a Recent SEC Filing